Adjuvant treatments in melanoma
For decades, interferon-alpha (IFN-α) has been the only option in the adjuvant treatment of high-risk melanoma. Despite numerous clinical trials and meta-analyzes, IFN-α is not yet a gold standard. It indeed showed benefit in progressionfree survival (PFS) and to a lesser extent in overall survival...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
University Hospital for Tumors
2021-01-01
|
| Col·lecció: | Libri Oncologici |
| Matèries: | |
| Accés en línia: | https://hrcak.srce.hr/file/389033 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|